1. Home
  2. CPSS vs TNXP Comparison

CPSS vs TNXP Comparison

Compare CPSS & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Consumer Portfolio Services Inc.

CPSS

Consumer Portfolio Services Inc.

HOLD

Current Price

$7.78

Market Cap

165.8M

Sector

Finance

ML Signal

HOLD

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

HOLD

Current Price

$12.93

Market Cap

172.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPSS
TNXP
Founded
1991
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
165.8M
172.7M
IPO Year
2010
2008

Fundamental Metrics

Financial Performance
Metric
CPSS
TNXP
Price
$7.78
$12.93
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
17.1K
407.6K
Earning Date
05-11-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
1.27
91.75
EPS
0.80
N/A
Revenue
$434,470,000.00
$13,107,000.00
Revenue This Year
$147.09
$558.11
Revenue Next Year
N/A
$38.29
P/E Ratio
$9.68
N/A
Revenue Growth
10.41
29.85
52 Week Low
$6.67
$11.60
52 Week High
$10.39
$69.65

Technical Indicators

Market Signals
Indicator
CPSS
TNXP
Relative Strength Index (RSI) 42.36 42.21
Support Level $7.38 $11.60
Resistance Level $8.48 $20.36
Average True Range (ATR) 0.25 1.13
MACD 0.02 -0.07
Stochastic Oscillator 15.29 24.03

Price Performance

Historical Comparison
CPSS
TNXP

About CPSS Consumer Portfolio Services Inc.

Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

Share on Social Networks: